<DOC>
	<DOC>NCT01634256</DOC>
	<brief_summary>The investigators performed a double-blind parallel study in a group of showing mild hepatic injury subjects who were given Fermented turmeric over a period of 12 weeks. The investigators measured liver function parameters , including ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(Alkaline Phosphatase), γ-GT(Gamma-Glutamyl Transferase), and serum bilirubin, and monitored their blood pressure.</brief_summary>
	<brief_title>A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury</brief_title>
	<detailed_description />
	<mesh_term>Turmeric extract</mesh_term>
	<criteria>Males and females 1970 years old Mild hepatic injury as indicated by ALT(Alanine Transaminase) level ≥ 40 Able to give informed consent Allergy or hypersensitivity to any of the ingredients in the test products History of reaction to any of the experimental products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery Carriers of viral hepatitis (type B and C) History of underlying Esophageal varices, hepatic encephalopathy, ascites(past 12 months) Participation in other clinical trials within the past 2 months Patients with acute hepatitis (type B and C) History of underlying cirrhosis and liver cancer History of underlying biliary diseases such as jaundice or gallstones History of underlying kidney disease such as Chronic renal failure or nephrotic syndrome Pregnant, planning to become pregnant, or breastfeeding Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>